142 related articles for article (PubMed ID: 4058271)
1. Antipyrine metabolism during hepatic regeneration in the rat.
Poulsen HE; Pilsgaard H
Liver; 1985 Aug; 5(4):196-9. PubMed ID: 4058271
[TBL] [Abstract][Full Text] [Related]
2. One sample antipyrine clearance after 90% partial hepatectomy in the rat.
Poulsen HE
Liver; 1985 Aug; 5(4):200-4. PubMed ID: 4058272
[TBL] [Abstract][Full Text] [Related]
3. Disposition of antipyrine in patients with extensive metastatic liver disease.
Robertz-Vaupel GM; Lindecken KD; Edeki T; Funke C; Belwon S; Dengler HJ
Eur J Clin Pharmacol; 1992; 42(5):465-9. PubMed ID: 1606991
[TBL] [Abstract][Full Text] [Related]
4. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
5. Antipyrine clearance and metabolism in patients with psoriasis.
Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
[TBL] [Abstract][Full Text] [Related]
6. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
[TBL] [Abstract][Full Text] [Related]
7. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and clinical utility of simplified tests of antipyrine metabolism.
Farrell GC; Zaluzny L
Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495
[TBL] [Abstract][Full Text] [Related]
9. Changes in the hepatic capacity of urea-N synthesis, galactose elimination and antipyrine clearance following 70% hepatectomy in the rat.
Adel Hansen B; Enghusen Poulsen H
Scand J Clin Lab Invest; 1986 May; 46(3):233-7. PubMed ID: 3520790
[TBL] [Abstract][Full Text] [Related]
10. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
13. The effect of age and sex on metabolism and urinary excretion of antipyrine.
Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
[TBL] [Abstract][Full Text] [Related]
14. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
Van Geel CA; Van Bezooijen CF
Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
[TBL] [Abstract][Full Text] [Related]
16. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
17. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.
Homeida M; Roberts CJ; Halliwell M; Read AE; Branch RA
Gut; 1979 Jul; 20(7):596-601. PubMed ID: 488757
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
19. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs.
Slørdal L; Høyem-Johansen T; Aarbakke J
Pharmacology; 1983; 26(2):95-9. PubMed ID: 6844394
[TBL] [Abstract][Full Text] [Related]
20. Influence of short-term water deprivation on antipyrine disposition in calves.
Janus K; Muszczynski Z; Suszycka J
Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
